6.
Davignon J, Ganz P
. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004; 109(23 Suppl 1):III27-32.
DOI: 10.1161/01.CIR.0000131515.03336.f8.
View
7.
Kruger-Genge A, Blocki A, Franke R, Jung F
. Vascular Endothelial Cell Biology: An Update. Int J Mol Sci. 2019; 20(18).
PMC: 6769656.
DOI: 10.3390/ijms20184411.
View
8.
Vanhoutte P, Shimokawa H, Feletou M, Tang E
. Endothelial dysfunction and vascular disease - a 30th anniversary update. Acta Physiol (Oxf). 2015; 219(1):22-96.
DOI: 10.1111/apha.12646.
View
9.
Rossetti P, Goldoni M, Pengo V, Vescovini R, Mozzoni P, Tassoni M
. MiRNA 126 as a New Predictor Biomarker in Venous Thromboembolism of Persistent Residual Vein Obstruction: A Review of the Literature Plus a Pilot Study. Semin Thromb Hemost. 2021; 47(8):982-991.
DOI: 10.1055/s-0041-1726341.
View
10.
Pawlak K, Mysliwiec M, Pawlak D
. Endocan--the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease. Clin Biochem. 2015; 48(6):425-30.
DOI: 10.1016/j.clinbiochem.2015.01.006.
View
11.
Tain Y, Hsu C
. Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA). Toxins (Basel). 2017; 9(3).
PMC: 5371847.
DOI: 10.3390/toxins9030092.
View
12.
Jezovnik M, Poredos P
. Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction. Int Angiol. 2010; 29(3):226-31.
View
13.
Lugo-Gavidia L, Burger D, Matthews V, Nolde J, Kiuchi M, Carnagarin R
. Role of Microparticles in Cardiovascular Disease: Implications for Endothelial Dysfunction, Thrombosis, and Inflammation. Hypertension. 2021; 77(6):1825-1844.
DOI: 10.1161/HYPERTENSIONAHA.121.16975.
View
14.
Jezovnik M, Poredos P, Stalc M
. Impairment of the vasodilatation capability of the brachial artery in patients with idiopathic venous thrombosis. J Atheroscler Thromb. 2010; 17(11):1190-8.
DOI: 10.5551/jat.4960.
View
15.
Petrozella L, Mahendroo M, Timmons B, Roberts S, McIntire D, Alexander J
. Endothelial microparticles and the antiangiogenic state in preeclampsia and the postpartum period. Am J Obstet Gynecol. 2012; 207(2):140.e20-6.
PMC: 3432453.
DOI: 10.1016/j.ajog.2012.06.011.
View
16.
Brodsky S, Zhang F, Nasjletti A, Goligorsky M
. Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol. 2004; 286(5):H1910-5.
DOI: 10.1152/ajpheart.01172.2003.
View
17.
Battinelli E, Murphy D, Connors J
. Venous thromboembolism overview. Hematol Oncol Clin North Am. 2012; 26(2):345-67, ix.
DOI: 10.1016/j.hoc.2012.02.010.
View
18.
Chen J, Jiang L, Yu X, Hu M, Zhang Y, Liu X
. Endocan: A Key Player of Cardiovascular Disease. Front Cardiovasc Med. 2022; 8:798699.
PMC: 8766991.
DOI: 10.3389/fcvm.2021.798699.
View
19.
Della Bella S, Calcaterra F, Bacci M, Carenza C, Pandolfo C, Ferrazzi P
. Pathologic up-regulation of TNFSF15-TNFRSF25 axis sustains endothelial dysfunction in unprovoked venous thromboembolism. Cardiovasc Res. 2019; 116(3):698-707.
DOI: 10.1093/cvr/cvz131.
View
20.
Banno K, Yoder M
. Tissue regeneration using endothelial colony-forming cells: promising cells for vascular repair. Pediatr Res. 2017; 83(1-2):283-290.
DOI: 10.1038/pr.2017.231.
View